150420165613

The US Government Invests 65 Million Euros to Harvest Medicinal Marijuana for Research Purposes

  • Though few are aware of it, for almost 50 years the US government has been investing heavily in the cultivation of marijuana for medicinal aims. The University of Mississippi is charged with carrying this out. 
150420165613

American federal authorities have always been averse to supporting the legalisation of cannabis. Although many will find it surprising, and it is largely unknown, since 1968 it has been investing large sums of money to grow cannabis for therapeutic applications.

Although it regularly presents a front opposed to everything related to marijuana, it seems clear that the government acknowledges its medical value, as it collaborates with the University of Mississippi on research into its applications; this plant can be a valuable medicine to treat a range of conditions, and the United States knows it. 

According to the experts, may be that the government wants to maintain a corner on the research, and establish obstacles impeding other independent groups from getting involved. In any case, just weeks ago the National Institute of Health granted some 65.2 million euros (68.8 million dollars) to this university to cultivate marijuana and analyse it. 

The aim is to ultimately operate a plantation of 30,000 plants with this aim and have a good amount of acreage to harvest, analyse and amass high-quality cannabis, with the benefit of every growing tool necessary. 

Currently this is the only place where the growing of marijuana for this purpose (research) is legal in the United States, and has been backed by the government itself. Cannabis activists and experts indicate that the time has come for the government to recognise that its past positions against the medical use of marijuana were mistaken. This could lead to the full-fledged legal recognition of this fact. 

16/04/2015

Comments from our readers

There are no comments yet. Would you like to be the first?

Leave a comment!

Contact us

x
Contact us